Leibniz Institute for Immunotherapy

Stem cell memory CAR T cells achieve complete remissions at low doses without chemotherapy preconditioning

Researchers developed a highly homogeneous population of stem cell memory T cells that exhibit superior expansion and persistence, enabling complete responses at low doses. The study showed a favorable tolerability profile and demonstrated the separation between beneficial effects and toxic consequences.